Skip to main content
Figure 1 | Critical Care

Figure 1

From: Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?

Figure 1

Boxplots grouped by Kidney Disease: improving global outcomes stage (0 vs. 1 or 2) and time. The measurement of urinary tissue inhibitor of metalloproteinase 2 (TIMP-2) combined with urinary insulin-like growth factor binding protein 7 (IGFBP-7) using the diagnostic test in 42 cardiac surgery patients revealed that the test was able to discriminate between patients without (dark grey) acute kidney injury (AKI) and those with (light grey) AKI on the first postoperative day (area under the receiver operating characteristic curve, 0.706). The x-axis is measurement time points 1 through 4. The y-axis is the combined concentration of [TIMP-2] × [IGFBP-7] (ng/ml)2/1,000.

Back to article page